APA (7th ed.) Citation

Li, Y., Inam, M., Hasan, M. W., Chen, K., Zhang, Z., Zhu, Y., . . . Li, M. (2024). Optimizing Antitumor Effect of Triple-Negative Breast Cancer via Rosmarinic Acid–β-Cyclodextrin Inclusion Complex. Pharmaceutics, 16(11), 1408. https://doi.org/10.3390/pharmaceutics16111408

Chicago Style (17th ed.) Citation

Li, Yuan, et al. "Optimizing Antitumor Effect of Triple-Negative Breast Cancer via Rosmarinic Acid–β-Cyclodextrin Inclusion Complex." Pharmaceutics 16, no. 11 (2024): 1408. https://doi.org/10.3390/pharmaceutics16111408.

MLA (9th ed.) Citation

Li, Yuan, et al. "Optimizing Antitumor Effect of Triple-Negative Breast Cancer via Rosmarinic Acid–β-Cyclodextrin Inclusion Complex." Pharmaceutics, vol. 16, no. 11, 2024, p. 1408, https://doi.org/10.3390/pharmaceutics16111408.